These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 11029885

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The value of p53 protein expression in gallbladder carcinoma: analysis of 60 cases.
    da Rocha AO, Coutinho LM, Scholl JG, Leboutte LD.
    Hepatogastroenterology; 2004; 51(59):1310-4. PubMed ID: 15362740
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. p53 and c-erbB-2 protein expression in adenocarcinomas and epithelial dysplasias of the gall bladder.
    Kamel D, Pääkkö P, Nuorva K, Vähäkangas K, Soini Y.
    J Pathol; 1993 May; 170(1):67-72. PubMed ID: 8100854
    [Abstract] [Full Text] [Related]

  • 5. [Immunohistochemical demonstration of pepsinogens I and II in the gallbladder].
    Roa I, Araya JC, Shiraishi T, Yatani R, Wistuba I, Villaseca M, de Aretxabala X.
    Rev Med Chil; 1992 Dec; 120(12):1351-8. PubMed ID: 1343374
    [Abstract] [Full Text] [Related]

  • 6. Aberrant p53 expression and the development of gallbladder carcinoma and adenoma.
    Wang SN, Chung SC, Tsai KB, Chai CY, Chang WT, Kuo KK, Chen JS, Lee KT.
    Kaohsiung J Med Sci; 2006 Feb; 22(2):53-9. PubMed ID: 16568721
    [Abstract] [Full Text] [Related]

  • 7. Expression of MUC1 and MUC2 mucin core proteins and their messenger RNA in gall bladder carcinoma: an immunohistochemical and in situ hybridization study.
    Yamato T, Sasaki M, Watanabe Y, Nakanuma Y.
    J Pathol; 1999 May; 188(1):30-7. PubMed ID: 10398137
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Analysis of trefoil factor family protein 1 (TFF1, pS2) expression in chronic cholecystitis and gallbladder carcinoma.
    Kornprat P, Rehak P, Lemmerer M, Gogg-Kamerer M, Langner C.
    Virchows Arch; 2005 May; 446(5):505-10. PubMed ID: 15821928
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [An early carcinoma of the gallbladder with atypical epithelium ( a report of a case with elevated p53 expression)].
    Yabar HA, Watanabe H.
    Rev Gastroenterol Peru; 1994 May; 14(1):65-8. PubMed ID: 8018902
    [Abstract] [Full Text] [Related]

  • 15. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas.
    Teh M, Wee A, Raju GC.
    Cancer; 1994 Sep 01; 74(5):1542-5. PubMed ID: 7520348
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [P53 gene mutation in gallbladder cancer].
    Roa I, Melo A, Roa J, Araya J, Villaseca M, de Aretxabala X.
    Rev Med Chil; 2000 Mar 01; 128(3):251-8. PubMed ID: 10962865
    [Abstract] [Full Text] [Related]

  • 18. Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumor development.
    Sasaki I, Yao T, Nawata H, Tsuneyoshi M.
    Cancer; 1999 Apr 15; 85(8):1719-29. PubMed ID: 10223565
    [Abstract] [Full Text] [Related]

  • 19. Allele-specific mutations involved in the pathogenesis of endemic gallbladder carcinoma in Chile.
    Wistuba II, Sugio K, Hung J, Kishimoto Y, Virmani AK, Roa I, Albores-Saavedra J, Gazdar AF.
    Cancer Res; 1995 Jun 15; 55(12):2511-5. PubMed ID: 7780959
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.